AU2010241006B9 - Resorbable and biocompatible fibre glass compositions and their uses - Google Patents
Resorbable and biocompatible fibre glass compositions and their uses Download PDFInfo
- Publication number
- AU2010241006B9 AU2010241006B9 AU2010241006A AU2010241006A AU2010241006B9 AU 2010241006 B9 AU2010241006 B9 AU 2010241006B9 AU 2010241006 A AU2010241006 A AU 2010241006A AU 2010241006 A AU2010241006 A AU 2010241006A AU 2010241006 B9 AU2010241006 B9 AU 2010241006B9
- Authority
- AU
- Australia
- Prior art keywords
- weight
- fibre
- glass
- copolymers
- implant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 83
- 239000011152 fibreglass Substances 0.000 title description 16
- 239000011521 glass Substances 0.000 claims description 66
- 239000000835 fiber Substances 0.000 claims description 52
- 229920001577 copolymer Polymers 0.000 claims description 39
- 239000003365 glass fiber Substances 0.000 claims description 39
- 229920000642 polymer Polymers 0.000 claims description 38
- 239000007943 implant Substances 0.000 claims description 34
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 29
- 229910052700 potassium Inorganic materials 0.000 claims description 29
- 239000011591 potassium Substances 0.000 claims description 29
- 239000011159 matrix material Substances 0.000 claims description 26
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 23
- 210000001519 tissue Anatomy 0.000 claims description 23
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 20
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 18
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 17
- 229910052708 sodium Inorganic materials 0.000 claims description 14
- 229920000331 Polyhydroxybutyrate Polymers 0.000 claims description 12
- 239000005015 poly(hydroxybutyrate) Substances 0.000 claims description 12
- 229920001897 terpolymer Polymers 0.000 claims description 11
- 210000000988 bone and bone Anatomy 0.000 claims description 9
- 239000000155 melt Substances 0.000 claims description 9
- -1 poly(ester anhydrides Chemical class 0.000 claims description 9
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 7
- 230000035876 healing Effects 0.000 claims description 7
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 7
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 7
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 7
- 229920002635 polyurethane Polymers 0.000 claims description 6
- 239000004814 polyurethane Substances 0.000 claims description 6
- 239000004753 textile Substances 0.000 claims description 6
- 229920001244 Poly(D,L-lactide) Polymers 0.000 claims description 5
- 229920000954 Polyglycolide Polymers 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 229920000117 poly(dioxanone) Polymers 0.000 claims description 5
- 229920000515 polycarbonate Polymers 0.000 claims description 5
- 239000004417 polycarbonate Substances 0.000 claims description 5
- 229920001710 Polyorthoester Polymers 0.000 claims description 4
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 claims description 4
- 229920000903 polyhydroxyalkanoate Polymers 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 230000008929 regeneration Effects 0.000 claims description 4
- 238000011069 regeneration method Methods 0.000 claims description 4
- 229920001187 thermosetting polymer Polymers 0.000 claims description 4
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 claims description 4
- ALRHLSYJTWAHJZ-UHFFFAOYSA-N 3-hydroxypropionic acid Chemical compound OCCC(O)=O ALRHLSYJTWAHJZ-UHFFFAOYSA-N 0.000 claims description 3
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 claims description 3
- 229920001651 Cyanoacrylate Polymers 0.000 claims description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 3
- 229920000388 Polyphosphate Polymers 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 229920000728 polyester Polymers 0.000 claims description 3
- 229920006149 polyester-amide block copolymer Polymers 0.000 claims description 3
- 229920002643 polyglutamic acid Polymers 0.000 claims description 3
- 239000001205 polyphosphate Substances 0.000 claims description 3
- 235000011176 polyphosphates Nutrition 0.000 claims description 3
- 229940068984 polyvinyl alcohol Drugs 0.000 claims 2
- 239000011734 sodium Substances 0.000 description 23
- 239000000395 magnesium oxide Substances 0.000 description 22
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 22
- 235000012255 calcium oxide Nutrition 0.000 description 21
- 238000000034 method Methods 0.000 description 19
- 239000000463 material Substances 0.000 description 14
- 239000012890 simulated body fluid Substances 0.000 description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
- 238000004090 dissolution Methods 0.000 description 9
- 239000005313 bioactive glass Substances 0.000 description 8
- 239000012620 biological material Substances 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 230000000975 bioactive effect Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229910052586 apatite Inorganic materials 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 239000011888 foil Substances 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 4
- 239000003513 alkali Substances 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229920000249 biocompatible polymer Polymers 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- MMCOUVMKNAHQOY-UHFFFAOYSA-N carbonoperoxoic acid Chemical class OOC(O)=O MMCOUVMKNAHQOY-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 231100000433 cytotoxic Toxicity 0.000 description 3
- 230000001472 cytotoxic effect Effects 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 230000001627 detrimental effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 238000001746 injection moulding Methods 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 238000010094 polymer processing Methods 0.000 description 3
- 229910001414 potassium ion Inorganic materials 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000007922 dissolution test Methods 0.000 description 2
- 239000012909 foetal bovine serum Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000010128 melt processing Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 231100000189 neurotoxic Toxicity 0.000 description 2
- 230000002887 neurotoxic effect Effects 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000009864 tensile test Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OXIKLRTYAYRAOE-CMDGGOBGSA-N (e)-3-(1-benzyl-3-pyridin-3-ylpyrazol-4-yl)prop-2-enoic acid Chemical compound N1=C(C=2C=NC=CC=2)C(/C=C/C(=O)O)=CN1CC1=CC=CC=C1 OXIKLRTYAYRAOE-CMDGGOBGSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 1
- 229910011255 B2O3 Inorganic materials 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 239000000899 Gutta-Percha Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 229910018068 Li 2 O Inorganic materials 0.000 description 1
- 229920000106 Liquid crystal polymer Polymers 0.000 description 1
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 240000000342 Palaquium gutta Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 229920003232 aliphatic polyester Polymers 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 210000001264 anterior cruciate ligament Anatomy 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical class [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 1
- 238000012303 cytoplasmic staining Methods 0.000 description 1
- 238000004031 devitrification Methods 0.000 description 1
- JKWMSGQKBLHBQQ-UHFFFAOYSA-N diboron trioxide Chemical compound O=BOB=O JKWMSGQKBLHBQQ-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000007380 fibre production Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000005816 glass manufacturing process Methods 0.000 description 1
- 239000000156 glass melt Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229920000588 gutta-percha Polymers 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000010309 melting process Methods 0.000 description 1
- 239000006060 molten glass Substances 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/026—Ceramic or ceramic-like structures, e.g. glasses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/10—Ceramics or glasses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L31/127—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing fillers of phosphorus-containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L31/128—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing other specific inorganic fillers not covered by A61L31/126 or A61L31/127
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C3/00—Glass compositions
- C03C3/04—Glass compositions containing silica
- C03C3/076—Glass compositions containing silica with 40% to 90% silica, by weight
- C03C3/078—Glass compositions containing silica with 40% to 90% silica, by weight containing an oxide of a divalent metal, e.g. an oxide of zinc
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C3/00—Glass compositions
- C03C3/04—Glass compositions containing silica
- C03C3/076—Glass compositions containing silica with 40% to 90% silica, by weight
- C03C3/089—Glass compositions containing silica with 40% to 90% silica, by weight containing boron
- C03C3/091—Glass compositions containing silica with 40% to 90% silica, by weight containing boron containing aluminium
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C3/00—Glass compositions
- C03C3/04—Glass compositions containing silica
- C03C3/076—Glass compositions containing silica with 40% to 90% silica, by weight
- C03C3/097—Glass compositions containing silica with 40% to 90% silica, by weight containing phosphorus, niobium or tantalum
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C4/00—Compositions for glass with special properties
- C03C4/0007—Compositions for glass with special properties for biologically-compatible glass
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C2201/00—Glass compositions
- C03C2201/06—Doped silica-based glasses
- C03C2201/08—Doped silica-based glasses containing boron or halide
- C03C2201/10—Doped silica-based glasses containing boron or halide containing boron
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C2201/00—Glass compositions
- C03C2201/06—Doped silica-based glasses
- C03C2201/20—Doped silica-based glasses containing non-metals other than boron or halide
- C03C2201/28—Doped silica-based glasses containing non-metals other than boron or halide containing phosphorus
-
- C—CHEMISTRY; METALLURGY
- C03—GLASS; MINERAL OR SLAG WOOL
- C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
- C03C2213/00—Glass fibres or filaments
- C03C2213/02—Biodegradable glass fibres
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Geochemistry & Mineralogy (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Ceramic Engineering (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Composite Materials (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Materials For Medical Uses (AREA)
- Glass Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09158608.1A EP2243749B1 (en) | 2009-04-23 | 2009-04-23 | Resorbable and biocompatible fibre glass compositions and their uses |
| EP09158608.1 | 2009-04-23 | ||
| PCT/EP2010/055192 WO2010122019A1 (en) | 2009-04-23 | 2010-04-20 | Resorbable and biocompatible fibre glass compositions and their uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2010241006A1 AU2010241006A1 (en) | 2011-10-13 |
| AU2010241006B2 AU2010241006B2 (en) | 2014-04-10 |
| AU2010241006B9 true AU2010241006B9 (en) | 2014-10-02 |
Family
ID=41095924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2010241006A Active AU2010241006B9 (en) | 2009-04-23 | 2010-04-20 | Resorbable and biocompatible fibre glass compositions and their uses |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20120040002A1 (enExample) |
| EP (2) | EP2243749B1 (enExample) |
| JP (1) | JP5689870B2 (enExample) |
| KR (1) | KR101742017B1 (enExample) |
| CN (2) | CN105797214A (enExample) |
| AU (1) | AU2010241006B9 (enExample) |
| BR (1) | BRPI1013728B8 (enExample) |
| CA (1) | CA2756395C (enExample) |
| CO (1) | CO6440586A2 (enExample) |
| CR (1) | CR20110516A (enExample) |
| IL (1) | IL215181A0 (enExample) |
| RU (1) | RU2558101C2 (enExample) |
| WO (1) | WO2010122019A1 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2243749B1 (en) * | 2009-04-23 | 2015-04-08 | PURAC Biochem BV | Resorbable and biocompatible fibre glass compositions and their uses |
| JP5711735B2 (ja) * | 2009-07-10 | 2015-05-07 | バイオ２ テクノロジーズ，インク． | 生体組織工学のためのデバイスおよび方法 |
| WO2014190289A2 (en) | 2013-05-23 | 2014-11-27 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants |
| US11484627B2 (en) | 2010-10-20 | 2022-11-01 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
| US11207109B2 (en) | 2010-10-20 | 2021-12-28 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
| US10525169B2 (en) | 2010-10-20 | 2020-01-07 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
| US11058796B2 (en) | 2010-10-20 | 2021-07-13 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
| WO2015095745A1 (en) | 2010-10-20 | 2015-06-25 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
| WO2012054742A2 (en) | 2010-10-20 | 2012-04-26 | BIOS2 Medical, Inc. | Implantable polymer for bone and vascular lesions |
| US11291483B2 (en) | 2010-10-20 | 2022-04-05 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants |
| CN102531385A (zh) * | 2012-01-17 | 2012-07-04 | 上海中山医疗科技发展公司 | 一种生物活性玻璃及其制备方法 |
| EP2819620A4 (en) | 2012-02-29 | 2015-11-04 | 206 Ortho Inc | METHOD AND APPARATUS FOR TREATING BONE FRACTURES, INCLUDING THE USE OF COMPOSITE IMPLANTS |
| CN102590255A (zh) * | 2012-02-29 | 2012-07-18 | 成都中光电科技有限公司 | 玻璃原材料主含量的检测方法 |
| KR102504497B1 (ko) | 2014-09-07 | 2023-02-27 | 오씨오 리미티드 | 이방성 생체복합재료 물질, 이를 포함하는 의학적 이식물 및 이의 치료방법 |
| CN107106210B (zh) | 2014-12-26 | 2021-05-04 | 奥西奥有限公司 | 连续纤维增强的生物复合材料医用植入物 |
| RU2603717C1 (ru) * | 2015-10-13 | 2016-11-27 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | СПОСОБ ОЦЕНКИ БИОИНЕРТНОСТИ МЕДИЦИНСКИХ ИМПЛАНТОВ in vivo |
| US10464849B2 (en) * | 2015-12-08 | 2019-11-05 | Edward J. A. Pope | Fast-densified ceramic matrix composite and fabrication method |
| WO2017155956A1 (en) * | 2016-03-07 | 2017-09-14 | Ossio Ltd | Surface treated biocomposite material, medical implants comprising same and methods of treatment thereof |
| US10647962B2 (en) * | 2016-05-27 | 2020-05-12 | Corning Incorporated | Bioactive aluminoborate glasses |
| US20170342383A1 (en) | 2016-05-27 | 2017-11-30 | Corning Incorporated | Lithium disilicate glass-ceramic compositions and methods thereof |
| US11491264B2 (en) | 2016-06-27 | 2022-11-08 | Ossio Ltd. | Fiber reinforced biocomposite medical implants with high mineral content |
| US10875806B2 (en) * | 2017-07-19 | 2020-12-29 | Corning Incorporated | Organic-inorganic composite fibers and methods thereof |
| KR102758177B1 (ko) | 2017-09-07 | 2025-01-22 | 오씨오 리미티드 | 섬유 강화 생체복합재 나사산 형성 임플란트 |
| ES2871104T3 (es) | 2017-10-16 | 2021-10-28 | Arctic Biomaterials Oy | Implantes bioabsorbibles ortopédicos |
| EP3717030A1 (en) | 2017-11-28 | 2020-10-07 | Corning Incorporated | Bioactive glass compositions and dentin hypersensitivity remediation |
| EP3717428A1 (en) | 2017-11-28 | 2020-10-07 | Corning Incorporated | Bioactive borate glass and methods thereof |
| CN111417601A (zh) | 2017-11-28 | 2020-07-14 | 康宁股份有限公司 | 化学强化的生物活性玻璃陶瓷 |
| EP3717427A1 (en) | 2017-11-28 | 2020-10-07 | Corning Incorporated | High liquidus viscosity bioactive glass |
| EP3727203A4 (en) | 2017-12-20 | 2021-08-25 | Ossio Ltd. | BIOCOMPOSITE MEDICAL IMPLANTS REINFORCED WITH FIBER BUNDLES |
| WO2020013980A1 (en) | 2018-07-09 | 2020-01-16 | Corning Incorporated | Organic-inorganic composites and methods of manufacturing thereof |
| ES2890488T3 (es) | 2018-10-24 | 2022-01-20 | Arctic Biomaterials Oy | Material compuesto biodegradable reforzado |
| EP3643691B1 (en) | 2018-10-24 | 2021-07-21 | Arctic Biomaterials Oy | Biodegradable, bioactive and biocompatible glass composition |
| JP7264368B2 (ja) * | 2019-01-29 | 2023-04-25 | 株式会社日本触媒 | 繊維強化材料、及び繊維強化材料の製造方法 |
| JP2020162921A (ja) * | 2019-03-29 | 2020-10-08 | 巨晰光纖股▲ふん▼有限公司 | 眼球排水用分流支持枠 |
| CN112390528B (zh) * | 2019-08-13 | 2024-09-27 | 康宁股份有限公司 | 生物活性玻璃组合物 |
| ES2935496T3 (es) | 2019-08-21 | 2023-03-07 | Bioretec Oy | Material compuesto, implante que lo comprende, uso del material compuesto y método para preparar un dispositivo médico |
| EP3818994A1 (en) * | 2019-11-08 | 2021-05-12 | Septodont ou Septodont SAS ou Specialites Septodont | Non-breaking filament for shaping bone and dental substitutes |
| US12383246B2 (en) | 2020-10-12 | 2025-08-12 | Abbott Cardiovascular Systems, Inc. | Vessel closure device with improved safety and tract hemostasis |
| IL294542A (en) | 2021-07-19 | 2023-02-01 | Ossio Ltd | A device with a tube for inserting implants with an adjustable insertion depth |
| EP4479352A1 (en) | 2022-02-16 | 2024-12-25 | Purac Biochem B.V. | Resorbable and biocompatible glass fiber bundle having a well-defined diameter and process for making such |
| TWI890935B (zh) | 2022-03-17 | 2025-07-21 | 巨晰光纖股份有限公司 | 用於再生醫材之生物玻璃纖維及其應用 |
| CN114796629B (zh) * | 2022-04-18 | 2024-05-24 | 北京纳通医学研究院有限公司 | 一种可吸收生物活性带线锚钉及其制备方法和应用 |
| CN115671400B (zh) * | 2022-10-27 | 2024-02-02 | 牛瑞瑞 | 一种复合可吸收植入物及其制备方法和用途 |
| CN116036386B (zh) * | 2023-02-22 | 2024-04-30 | 天津纳博特医疗器械有限公司 | 一种可吸收玻纤增强聚乳酸复合材料及颅颌面钉板系统 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2658182B1 (fr) * | 1990-02-09 | 1993-11-26 | Isover Saint Gobain | Fibres de verre susceptibles de se decomposer en milieu biologique. |
| AU630484B2 (en) | 1989-08-11 | 1992-10-29 | Isover Saint-Gobain | Glass fibres capable of decomposing in a physiological medium |
| FR2699402B1 (fr) | 1992-12-18 | 1995-02-17 | Composites Develloppement | Matériau composite haute performance notamment pour usage dentaire et médical et son procédé d'obtention. |
| US5468544A (en) * | 1993-11-15 | 1995-11-21 | The Trustees Of The University Of Pennsylvania | Composite materials using bone bioactive glass and ceramic fibers |
| FI101129B (sv) | 1995-01-13 | 1998-04-30 | Vivoxid Oy | Nya bioaktiva glas och deras användning |
| RU2105529C1 (ru) * | 1995-06-30 | 1998-02-27 | Клиническое научно-производственное объединение "Биотехника" | Хирургическое устройство и керамический биоактивный материал для остеосинтеза |
| US5945360A (en) | 1997-03-28 | 1999-08-31 | Johns Manville International, Inc. | Biosoluble pot and marble-derived fiberglass |
| US5977204A (en) | 1997-04-11 | 1999-11-02 | Osteobiologics, Inc. | Biodegradable implant material comprising bioactive ceramic |
| DE69840171D1 (de) * | 1997-05-30 | 2008-12-11 | Osteobiologics Inc | Faserverstärkte,poröse,biologisch abbaubare implantatvorrichtung |
| WO1999020692A1 (en) | 1997-10-23 | 1999-04-29 | University Of Florida | Bioactive composites comprising silane functionalized polyaryl polymers |
| FR2781788B1 (fr) * | 1998-08-03 | 2001-08-10 | Saint Gobain Isover | Composition de laine minerale |
| SI1048625T1 (en) * | 1999-04-30 | 2004-06-30 | Ursa International Gmbh | Biosoluble composition of glass fibres for the production of glass wools and the like |
| US6482444B1 (en) | 1999-06-14 | 2002-11-19 | Imperial College Innovations | Silver-containing, sol/gel derived bioglass compositions |
| US7597900B2 (en) * | 2001-03-27 | 2009-10-06 | Schott Ag | Tissue abrasives |
| ATE332879T1 (de) | 2001-08-22 | 2006-08-15 | Schott Ag | Antimikrobielles, entzündungshemmendes, wundheilendes glaspulver und dessen verwendung |
| ES2244826T3 (es) * | 2001-12-12 | 2005-12-16 | Schott Ag | Uso de una vitroceramica antimicrobiana para cuidado dental e higiene bucal. |
| JP2003212596A (ja) | 2002-01-23 | 2003-07-30 | Paramount Glass Kogyo Kk | 無機質繊維製造用硝子組成物、その製造方法及びその無機質繊維成型物 |
| ATE322295T1 (de) | 2002-10-03 | 2006-04-15 | Vivoxid Oy | Bioaktive glaszusammensetzung |
| US7270813B2 (en) | 2002-10-08 | 2007-09-18 | Osteotech, Inc. | Coupling agents for orthopedic biomaterials |
| FI20030780A0 (fi) * | 2003-05-23 | 2003-05-23 | Bioxid Oy | Prepreg ja sen käyttö |
| US7617490B2 (en) | 2003-09-10 | 2009-11-10 | Intel Corporation | Methods and apparatus for dynamic best fit compilation of mixed mode instructions |
| EP1655042A1 (en) * | 2004-11-02 | 2006-05-10 | Vivoxid Oy | A medical device |
| US7959940B2 (en) * | 2006-05-30 | 2011-06-14 | Advanced Cardiovascular Systems, Inc. | Polymer-bioceramic composite implantable medical devices |
| FI124017B (fi) * | 2006-06-30 | 2014-01-31 | Stick Tech Oy | Kovettavat kuitulujitetut komposiitit ja menetelmä aplikaatio-orientuneiden kuitulujitettujen komposiittien valmistamiseksi |
| FR2905695B1 (fr) * | 2006-09-13 | 2008-10-24 | Saint Gobain Isover Sa | Compositions pour laines minerales |
| EP1958925A1 (en) | 2007-02-13 | 2008-08-20 | Vivoxid Oy | A system and method for manufacturing fibres |
| PL2243500T3 (pl) * | 2009-04-23 | 2012-06-29 | Purac Biochem Bv | Biozgodny kompozyt i jego zastosowanie |
| EP2243749B1 (en) * | 2009-04-23 | 2015-04-08 | PURAC Biochem BV | Resorbable and biocompatible fibre glass compositions and their uses |
-
2009
- 2009-04-23 EP EP09158608.1A patent/EP2243749B1/en active Active
-
2010
- 2010-04-20 AU AU2010241006A patent/AU2010241006B9/en active Active
- 2010-04-20 WO PCT/EP2010/055192 patent/WO2010122019A1/en not_active Ceased
- 2010-04-20 US US13/265,832 patent/US20120040002A1/en not_active Abandoned
- 2010-04-20 CN CN201610094871.3A patent/CN105797214A/zh active Pending
- 2010-04-20 CN CN2010800178875A patent/CN102421716A/zh active Pending
- 2010-04-20 EP EP10715532A patent/EP2421803A1/en not_active Withdrawn
- 2010-04-20 BR BRPI1013728A patent/BRPI1013728B8/pt active IP Right Grant
- 2010-04-20 CA CA2756395A patent/CA2756395C/en active Active
- 2010-04-20 RU RU2011147379/03A patent/RU2558101C2/ru active
- 2010-04-20 KR KR1020117024651A patent/KR101742017B1/ko active Active
- 2010-04-20 JP JP2012506468A patent/JP5689870B2/ja active Active
-
2011
- 2011-09-15 IL IL215181A patent/IL215181A0/en unknown
- 2011-10-03 CR CR20110516A patent/CR20110516A/es unknown
- 2011-10-18 CO CO11138645A patent/CO6440586A2/es not_active Application Discontinuation
-
2014
- 2014-04-04 US US14/245,071 patent/US9381277B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR101742017B1 (ko) | 2017-05-31 |
| US9381277B2 (en) | 2016-07-05 |
| JP2012524705A (ja) | 2012-10-18 |
| IL215181A0 (en) | 2011-12-29 |
| AU2010241006B2 (en) | 2014-04-10 |
| EP2243749A1 (en) | 2010-10-27 |
| RU2558101C2 (ru) | 2015-07-27 |
| CN105797214A (zh) | 2016-07-27 |
| RU2011147379A (ru) | 2013-05-27 |
| CR20110516A (es) | 2012-01-19 |
| CN102421716A (zh) | 2012-04-18 |
| BRPI1013728B8 (pt) | 2021-07-27 |
| JP5689870B2 (ja) | 2015-03-25 |
| US20120040002A1 (en) | 2012-02-16 |
| BRPI1013728B1 (pt) | 2021-04-06 |
| WO2010122019A1 (en) | 2010-10-28 |
| EP2421803A1 (en) | 2012-02-29 |
| EP2243749B1 (en) | 2015-04-08 |
| CA2756395A1 (en) | 2010-10-28 |
| US20140220338A1 (en) | 2014-08-07 |
| AU2010241006A1 (en) | 2011-10-13 |
| KR20120026036A (ko) | 2012-03-16 |
| CO6440586A2 (es) | 2012-05-15 |
| BRPI1013728A2 (pt) | 2016-04-05 |
| CA2756395C (en) | 2017-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2010241006B9 (en) | Resorbable and biocompatible fibre glass compositions and their uses | |
| Kitsugi et al. | Bone bonding behavior of MgO CaO SiO2 P2O5 CaF2 glass (mother glass of A· W‐glass‐ceramics) | |
| AU2007325001B2 (en) | Fiber reinforced composite material | |
| AU2010240904B2 (en) | Biocompatible composite and its use | |
| FI117963B (fi) | Luuta korvaavat materiaalit | |
| Ali et al. | Novel biodegradable hybrid composite of polylactic acid (PLA) matrix reinforced by bioactive glass (BG) fibres and magnesium (Mg) wires for orthopaedic application | |
| ES2893241T3 (es) | Composición de vidrio biodegradable, bioactivo y biocompatible | |
| Huttunen et al. | Fiber-reinforced bioactive and bioabsorbable hybrid composites | |
| JP2019535338A (ja) | 骨インプラント | |
| Hossain et al. | Phosphate glass fibres and their composites | |
| Ahmed et al. | Biodegradable composite materials as bone regenerative implants | |
| WO2024121092A1 (en) | A process for manufacturing a resorbable composite biomaterial, the resorbable biomaterial produced, and its use in various applications | |
| BR112023012662B1 (pt) | Implante que compreende liga de magnésio e método para preparação do mesmo | |
| Kellomäki | SRIJANA GHIMIRE IN VITRO AND MECHANICAL PROPERTIES OF BIOACTIVE-GLASS/POLYMER COMPOSITES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: PURAC BIOCHEM BV Free format text: FORMER APPLICANT(S): VIVOXID OY |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| SREP | Specification republished |